510(k) Report

510(k) · Cleared

Cleared

Aia-Pack RBC Folate

K091332510(k) TraditionalCleared Oct 2, 2009149-day reviewClass II21 CFR 862.1295

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tosoh Bioscience, Inc. · CGN Acid, Folic, Radioimmunoassay

Cleared on Oct 2, 2009 as substantially equivalent to K010050 (Bayer Diagnostics Corp., 2001) after a 149-day review. Its family tree reaches back 1 generation to 2001.

Decided
Oct 2, 2009
Review
149 days
Class
Class II
Product code
CGN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K010050 (2001). No later device cites it as a predicate yet.

K010050 · Advia Centaur and Acs: 180 Folate Immunoassay · Bayer Diagnostics Corp. · 2001 · recalled200020022004200620082010
  1. Root · 1 generation backK010050 Advia Centaur and Acs: 180 Folate ImmunoassayBayer Diagnostics Corp. · 2001 · Recalled
  2. This deviceK091332 Aia-Pack RBC FolateTosoh Bioscience, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K010050Advia Centaur and Acs: 180 Folate ImmunoassayBayer Diagnostics Corp.200114
0 (this device)K091332Aia-Pack RBC FolateTosoh Bioscience, Inc.2009—
FIG. 1 — Lineage of K091332, 2001–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGN device

  1. #1 K233060 Elecsys Folate IIIscore 9.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010050Advia Centaur and Acs: 180 Folate Immunoassay
Summary page 2
…ication Name: Class II CGN 21 CFR 862.1295 Folic Acid Test System Predicate Device: K010050, ADVIA Centaur and ACS: 180 Folate Immunoassay, Manufactured by Bayer Diagnostics…
Bayer Diagnostics Corp.200114

Also cleared against K010050: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 2 other devices also cite its predicate K010050.

How does its category compare?

All CGN devices

CGN Acid, Folic, Radioimmunoassay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · CGN

1in 2024

2009: 22010: 12011: 12014: 12016: 12018: 12020: 12023: 12024: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGN

Too few CGN 510(k)s in any year since 2007 to give a median.

Recalls per year · CGN

3in 2019

2007: 22008: 12009: 12010: 12012: 22013: 12018: 22019: 3
2007high 3 (2019) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CGN

9in 2025

2007: 262009: 32011: 282012: 112013: 22014: 42015: 12016: 42017: 62018: 22019: 12020: 52021: 32022: 132023: 82024: 192025: 9
2007high 28 (2011) · low 0 (2008)2025

MAUDE reports naming product code CGN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—226
20080—10
20092—13
20101—10
20111—028
20120—211
20130—12
20141—04
20150—01
20161—04
20170—06
20181—22
20190—31
20201—05
20210—03
20220—013
20231—08
20241—019
20250—09
20260—0—

What is it indicated for?

Tosoh AIA-PACK RBC FOLATE is designed for in vitro diagnostic use only for the quantitative measurement of red blood cell folate (RBC FOLATE) in whole blood (Heparin or EDTA) samples on TOSOH AIA system analyzer. Measurement of RBC Folate is used in the diagnosis and treatment of anemia.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K091332: Aia-Pack RBC Folate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K091332

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026